M Galli1, G Finazzi, T Barbui. Show Affiliations » 1. Department of Haematology, Ospedali Riuniti, Bergamo, Italy.
Abstract
Entities: Disease
Mesh: See more » Antibodies, Antiphospholipid/metabolismAnticoagulants/therapeutic useAntiphospholipid Syndrome/diagnosisAntiphospholipid Syndrome/metabolismBlood Platelets/metabolismGranulocyte-Macrophage Colony-Stimulating Factor/adverse effectsGranulocyte-Macrophage Colony-Stimulating Factor/therapeutic useHumansInterleukin-3/adverse effectsInterleukin-3/therapeutic useRecombinant Fusion Proteins/adverse effectsRecombinant Fusion Proteins/therapeutic useThrombocytopenia/drug therapyThrombocytopenia/etiologyThrombocytopenia/metabolismThrombosis/complicationsThrombosis/metabolism
Substances: See more » Antibodies, AntiphospholipidAnticoagulantsInterleukin-3PIXY321 fusion protein, recombinantRecombinant Fusion ProteinsGranulocyte-Macrophage Colony-Stimulating Factor
Year: 1996 PMID: 8611440 DOI: 10.1046/j.1365-2141.1996.390969.x
Source DB: PubMed Journal: Br J Haematol ISSN: 0007-1048 Impact factor: 6.998